Researchers Treat Mesothelioma with Precision Medicine
Targeted therapy aimed at specific genetic mutations can lead to significant improvement in progression-free survival for many cancer patients, including those with mesothelioma, a recent study shows. The research team at Intermountain Precision Genomics in St. George, Utah, found that matching tumor-related genetic mutations to drugs specific to the corresponding abnormality slows or stops many…
The post Researchers Treat Mesothelioma with Precision Medicine appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.